4.7 Article

Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

How selective are clinical CDK4/6 inhibitors?

Denisa Hendrychova et al.

Summary: Pharmacological inhibition of CDK4/6 has shown promising results in treating breast cancer and other cancers, with complex cellular responses and multiple mechanisms involved. It is crucial to comprehensively characterize the selectivity profiles of these inhibitors for maximizing clinical efficacy and safety, as well as for potential repurposing in treating additional diseases.

MEDICINAL RESEARCH REVIEWS (2021)

Article Chemistry, Medicinal

Development of selective mono or dual PROTAC degrader probe of CDK isoforms

Fei Zhou et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Cell Biology

RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2

Laura Gonzalez et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)

Article Multidisciplinary Sciences

Quantifying CDK inhibitor selectivity in live cells

Carrow I. Wells et al.

NATURE COMMUNICATIONS (2020)

Article Chemistry, Medicinal

Discovery of MFH290: A Potent and Highly Selective Covalent Inhibitor for Cyclin-Dependent Kinase 12/13

Yao Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2019)

Article Chemistry, Medicinal

How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?

Radek Jorda et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss

Robert A. Hazlitt et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Structural insights into the functional diversity of the CDK-cyclin family

Daniel J. Wood et al.

OPEN BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Type II Inhibitors Targeting CDK2

Leila T. Alexander et al.

ACS CHEMICAL BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Identification and Characterization of an Irreversible Inhibitor of CDK2

Elizabeth Anscombe et al.

CHEMISTRY & BIOLOGY (2015)

Review Biotechnology & Applied Microbiology

The history and future of targeting cyclin-dependent kinases in cancer therapy

Uzma Asghar et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Chemistry, Organic

New Imidazo[1,2-c]pyrimidin-5(6H)-Ones Derived from Cytosine: Synthesis, Structure, and Cytotoxic Activity

Josef Jansa et al.

JOURNAL OF HETEROCYCLIC CHEMISTRY (2015)

Article Multidisciplinary Sciences

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Nicholas Kwiatkowski et al.

NATURE (2014)

Review Biotechnology & Applied Microbiology

Cyclin-dependent kinases

Marcos Malumbres

GENOME BIOLOGY (2014)

Article Biochemistry & Molecular Biology

An Integrated Chemical Biology Approach Provides Insight into Cdk2 Functional Redundancy and Inhibitor Sensitivity

Aude Echalier et al.

CHEMISTRY & BIOLOGY (2012)

Article Biochemical Research Methods

MolProbity: all-atom structure validation for macromolecular crystallography

Vincent B. Chen et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Chemistry, Multidisciplinary

The MORPHEUS protein crystallization screen

Fabrice Gorrec

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)

Review Oncology

Cell cycle, CDKs and cancer: a changing paradigm

Marcos Malumbres et al.

NATURE REVIEWS CANCER (2009)

Article Biochemical Research Methods

Coot:: model-building tools for molecular graphics

P Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)